December 2020. Volume 16. Number 4

Lidocaine or amiodarone for paediatric in-hospital cardiac arrest: both useful

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Holmberg MJ, Ross CE, Atkins DL, Valdés SO, Donnino MW, Andersen LW, et al. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: an observational study. Resuscitation. 2020;149:191-201.

Reviewers: de Lucas García N1, Pérez-Moneo Agapito B2.
1Pediatra. SAMUR-Protección Civil de Madrid. Grupo Español de RCP pediátrica y neonatal (GERCPPYN). Comité Científico Pediátrico del European Resuscitation Council. Madrid. España.
2Servicio de Pediatría. Hospital Universitario Infanta Leonor. Universidad Complutense. Madrid. España.
Correspondence: Nieves de Lucas García. Email: delucasn@gmail.com
Reception date: 18/09/2020
Acceptance date: 12/10/2020
Publication date: 04/11/2020

Abstract

Authors’ conclusions: there were no statistically significant differences in return of spontaneous circulation, survival to 24 hours, survival to hospital discharge, and favourable neurological outcome between children receiving amiodarone or lidocaine for shock-refractory ventricular fibrillation and pulseless ventricular tachycardia. These findings support the current paediatric cardiac arrest guidelines.

Reviewers’ commentary: both the administration of amiodarone and lidocaine are equivalent options in terms of the outcome achieved in the treatment of ventricular rhythms in paediatric intrahospital cardiac arrest, which is why each one can choose between one or the other according to protocols, local habits or particularizations related to possible adverse effects for the patient.

How to cite this article

De Lucas García N, Pérez-Moneo Agapito B. Lidocaína o amiodarona en parada cardiorrespiratoria pediátrica intrahospitalaria: ambas útiles. Evid Pediatr. 2020;16:46.

AVC | Critically appraised articles

Holmberg MJ, Ross CE, Atkins DL, Valdés SO, Donnino MW, Andersen LW, et al. Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: an observational study. Resuscitation. 2020;149:191-201.

Reviewers: de Lucas García N1, Pérez-Moneo Agapito B2.
1Pediatra. SAMUR-Protección Civil de Madrid. Grupo Español de RCP pediátrica y neonatal (GERCPPYN). Comité Científico Pediátrico del European Resuscitation Council. Madrid. España.
2Servicio de Pediatría. Hospital Universitario Infanta Leonor. Universidad Complutense. Madrid. España.
Correspondence: Nieves de Lucas García. Email: delucasn@gmail.com
Reception date: 18/09/2020
Acceptance date: 12/10/2020
Publication date: 04/11/2020

How to cite this article

De Lucas García N, Pérez-Moneo Agapito B. Lidocaína o amiodarona en parada cardiorrespiratoria pediátrica intrahospitalaria: ambas útiles. Evid Pediatr. 2020;16:46.

04/11/2020

Linked Comment